Lewy body dementia (LBD) distinguishes itself from Alzheimer’s disease and other forms of dementia due to the presence of abnormal protein deposits called Lewy bodies in the brain. These deposits contribute to a spectrum of symptoms encompassing cognitive decline, memory loss, and behavioral changes. What sets LBD apart are its hallmark features: vivid visual hallucinations, fluctuations in cognitive abilities, and Parkinson's-like motor symptoms such as muscle rigidity and tremors. Unlike Alzheimer’s, where memory loss predominates early stages, LBD often presents with a blend of cognitive, movement, and psychiatric symptoms right from the onset. Effective management involves a comprehensive approach, integrating medication, supportive therapies, and personalized lifestyle adjustments. Timely diagnosis and ongoing care are critical in addressing symptoms and enhancing quality of life for individuals affected by LBD.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China